REGENERON PHARMACEUTICALS, INC. Quarterly Return On Equity in % from Q4 2010 to Q2 2024

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Regeneron Pharmaceuticals, Inc. quarterly/annual Return On Equity history and growth rate from Q4 2010 to Q2 2024.
  • Regeneron Pharmaceuticals, Inc. Return On Equity for the quarter ending June 30, 2024 was 16.3 %, a 13.2% decline year-over-year.
  • Regeneron Pharmaceuticals, Inc. annual Return On Equity for 2023 was 16.1 %, a 21.5% decline from 2022.
  • Regeneron Pharmaceuticals, Inc. annual Return On Equity for 2022 was 20.5 %, a 60% decline from 2021.
  • Regeneron Pharmaceuticals, Inc. annual Return On Equity for 2021 was 51.2 %, a 54.2% increase from 2020.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q2 2024 16.3 -2.47 -13.2% Apr 1, 2024 Jun 30, 2024
Q1 2024 15.2 -3.81 -20.1% Jan 1, 2024 Mar 31, 2024
Q4 2023 16.1 -4.41 -21.5% Oct 1, 2023 Dec 31, 2023
Q3 2023 16.8 -9.79 -36.8% Jul 1, 2023 Sep 30, 2023
Q2 2023 18.8 -10.9 -36.8% Apr 1, 2023 Jun 30, 2023
Q1 2023 19 -25.7 -57.6% Jan 1, 2023 Mar 31, 2023
Q4 2022 20.5 -30.7 -60% Oct 1, 2022 Dec 31, 2022
Q3 2022 26.6 -23.9 -47.4% Jul 1, 2022 Sep 30, 2022
Q2 2022 29.7 -21.8 -42.3% Apr 1, 2022 Jun 30, 2022
Q1 2022 44.7 +6.69 +17.6% Jan 1, 2022 Mar 31, 2022
Q4 2021 51.2 +18 +54.2% Oct 1, 2021 Dec 31, 2021
Q3 2021 50.5 +20.8 +69.7% Jul 1, 2021 Sep 30, 2021
Q2 2021 51.4 +23.6 +84.4% Apr 1, 2021 Jun 30, 2021
Q1 2021 38 +17 +81.1% Jan 1, 2021 Mar 31, 2021
Q4 2020 33.2 +12.4 +60% Oct 1, 2020 Dec 31, 2020
Q3 2020 29.8 +7.47 +33.5% Jul 1, 2020 Sep 30, 2020
Q2 2020 27.9 +4.79 +20.7% Apr 1, 2020 Jun 30, 2020
Q1 2020 21 -8.23 -28.2% Jan 1, 2020 Mar 31, 2020
Q4 2019 20.8 -11.4 -35.5% Oct 1, 2019 Dec 31, 2019
Q3 2019 22.3 -3.6 -13.9% Jul 1, 2019 Sep 30, 2019
Q2 2019 23.1 -1.42 -5.79% Apr 1, 2019 Jun 30, 2019
Q1 2019 29.2 +5.68 +24.2% Jan 1, 2019 Mar 31, 2019
Q4 2018 32.2 +11 +51.6% Oct 1, 2018 Dec 31, 2018
Q3 2018 25.9 +1.42 +5.8% Jul 1, 2018 Sep 30, 2018
Q2 2018 24.5 +0.63 +2.64% Apr 1, 2018 Jun 30, 2018
Q1 2018 23.5 +1.97 +9.15% Jan 1, 2018 Mar 31, 2018
Q4 2017 21.2 -0.12 -0.56% Oct 1, 2017 Dec 31, 2017
Q3 2017 24.5 +4.52 +22.7% Jul 1, 2017 Sep 30, 2017
Q2 2017 23.9 +3.8 +18.9% Apr 1, 2017 Jun 30, 2017
Q1 2017 21.5 +0.44 +2.09% Jan 1, 2017 Mar 31, 2017
Q4 2016 21.3 +2.16 +11.3% Oct 1, 2016 Dec 31, 2016
Q3 2016 20 +1.16 +6.17% Jul 1, 2016 Sep 30, 2016
Q2 2016 20.1 +4.52 +29% Apr 1, 2016 Jun 30, 2016
Q1 2016 21.1 +7.85 +59.3% Jan 1, 2016 Mar 31, 2016
Q4 2015 19.2 +5.22 +37.4% Oct 1, 2015 Dec 31, 2015
Q3 2015 18.8 +3.63 +23.9% Jul 1, 2015 Sep 30, 2015
Q2 2015 15.6 -4 -20.4% Apr 1, 2015 Jun 30, 2015
Q1 2015 13.3 -8.16 -38.1% Jan 1, 2015 Mar 31, 2015
Q4 2014 14 -11.9 -46.1% Oct 1, 2014 Dec 31, 2014
Q3 2014 15.2 -39.4 -72.2% Jul 1, 2014 Sep 30, 2014
Q2 2014 19.6 -48.8 -71.4% Apr 1, 2014 Jun 30, 2014
Q1 2014 21.4 -61 -74% Jan 1, 2014 Mar 31, 2014
Q4 2013 25.9 -88.4 -77.3% Oct 1, 2013 Dec 31, 2013
Q3 2013 54.6 +5.79 +11.9% Jul 1, 2013 Sep 30, 2013
Q2 2013 68.4 +75.8 Apr 1, 2013 Jun 30, 2013
Q1 2013 82.4 +131 Jan 1, 2013 Mar 31, 2013
Q4 2012 114 +161 Oct 1, 2012 Dec 31, 2012
Q3 2012 48.8 +86.3 Jul 1, 2012 Sep 30, 2012
Q2 2012 -7.42 +25.6 +77.5% Apr 1, 2012 Jun 30, 2012
Q1 2012 -49 -22.4 -84.1% Jan 1, 2012 Mar 31, 2012
Q4 2011 -46.4 -20.9 -81.5% Oct 1, 2011 Dec 31, 2011
Q3 2011 -37.5 Jul 1, 2011 Sep 30, 2011
Q2 2011 -33 Apr 1, 2011 Jun 30, 2011
Q1 2011 -26.6 Jan 1, 2011 Mar 31, 2011
Q4 2010 -25.6 Oct 1, 2010 Dec 31, 2010
* An asterisk sign (*) next to the value indicates that the value is likely invalid.